Bone News and Research

RSS

Ingredients for an "anti-aging potion"

Aging without getting old? It's largely possible, according to the June issue of Mayo Clinic Health Letter.

24 Jun 2010

Spanish scientists propose human amniotic membrane as new tool for repairing damaged articular cartilage

Spanish scientists have proposed using human amniotic membrane as a new tool for repairing damaged human articular cartilage, which heals very poorly because of its low capacity for self-repair. Their research, published in the journal Cell and Tissue Banking, shows that the cellular density of the cartilage synthesised could be greater than that of the body's own natural cartilage.

23 Jun 2010

Global weight management ingredients market to reach $13.9 million by 2015

Obesity rates, which have been steadily rising in Europe and the United States, are now increasing in Asian nations as well. While healthy eating and lifestyle management are the key solutions to weight management, they remain challenging for many consumers. As a result, the weight management ingredients market offers significant prospects worldwide.

23 Jun 2010

Karolinska Institutet receives SEK 100M grant for Wallenberg Institute for Regenerative Medicine

Karolinska Institutet has received a grant of SEK 100 million from the Knut and Alice Wallenberg Foundation for a regenerative medicine research centre - the Wallenberg Institute for Regenerative Medicine (WIRM). This funding will give Karolinska Institutet a unique opportunity to concentrate on new and pioneering research, with a special focus on the blood system.

23 Jun 2010

Corgenix receives new European patent for AtherOx technology

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, announced today the issuance of one new European patent for the company's AtherOx® (oxLDL/B2GPI) technology and the publication of an important clinical trial studying oxLDL/B2GPI levels in patients with acute coronary syndrome (ACS).

23 Jun 2010

Elevation of Smurf1 may play a role in molecular basis of PAH: Study

Pulmonary arterial hypertension (PAH) is a progressive disease, marked by shortness of breath and fatigue which can be fatal if untreated. Increased pressure in the pulmonary artery and its branches is associated with dysfunctional growth control of endothelial and smooth muscle cells leading to excessive thickening of the blood vessel wall, obliteration of the lumen and right heart failure.

22 Jun 2010

KYPHON ActivOs 10 Bone Cement with HA launched to treat patients with VCFs

Medtronic, Inc. today announced the launch of KYPHON ActivOs 10 Bone Cement with Hydroxyapatite, a polymethylmethacrylate bone cement containing hydroxyapatite for use in the treatment of patients with vertebral compression fractures who are undergoing minimally invasive surgery with KYPHON Balloon Kyphoplasty.

22 Jun 2010

Enobia reports positive interim data from ENB-0040 enzyme replacement therapy study for children with HPP

Enobia Pharma today announced positive interim data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After 12 weeks of treatment with ENB-0040, children with HPP showed marked improvements in bone mineralization and function including increases in strength, endurance and mobility and reduction in pain. These findings were presented by Dr. Michael Whyte at ENDO 2010, the 92nd Annual Meeting of The Endocrine Society.

22 Jun 2010

Pfizer announces voluntary withdrawal of Mylotarg from U.S. market following FDA request

Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.

22 Jun 2010

Four-year clinical study results show sustained effect that Rheos System has on reducing hypertension

CVRx, Inc. announced today the four-year Rheos clinical results from the European study evaluating the Rheos System at the European Society of Hypertension 20th Meeting. The system is the first device designed to treat hypertension (high blood pressure), a leading cause of heart and kidney disease, stroke and death. This device is a future treatment option for the millions of people who cannot control their blood pressure with medications.

22 Jun 2010

MDT aligned with AAP position statement on efforts to be made to save patient's natural dentition

Millennium Dental Technologies, Inc. (MDT), pioneers of the patented LANAP™ protocol for the treatment of gum disease and the manufacturer of the PerioLase® MVP-7™ digital dental laser, are aligned with the American Academy of Periodontology (AAP) position statement that "efforts should be made to save a patient's natural dentition."

21 Jun 2010

Gamida Cell-Teva Joint Venture's StemEx program receives FDA Fast Track Designation

Gamida Cell announced today that the Gamida Cell-Teva Joint Venture has received an FDA Fast Track Designation for StemEx, in development as an alternative to a bone marrow transplant for patients with blood cancers such as leukemia and lymphoma.

21 Jun 2010

Ostarine increases muscle mass and strength in postmenopausal women: Study

GTx, Inc. announced that Ostarine (GTx-024, formerly MK-2866) increased lean body mass and leg press strength in a head to head study evaluating Ostarine and another selective androgen receptor modulator, MK-3984, in postmenopausal women. The data were presented yesterday at the 2010 Annual Meeting of the Endocrine Society. GTx is developing its lead SARM, Ostarine, for the treatment of cancer induced muscle wasting (cancer cachexia).

21 Jun 2010

Research findings open door to new model for health and fitness measurement

A University of Southern California study appearing in the current issue of peer-review journal, Nutrition Research reports that the user-friendly, Web-native Stayhealthy BC1 System offers clinical-grade body composition analysis comparable to the most rigorous clinical tools. According to the company, the study's findings open the door to a new, far more effective and engaging model for health and fitness measurement, reporting body composition analysis, rather than body weight or the outdated body mass index.

19 Jun 2010

ThermoGenesis to seek stockholder approval for reverse stock split

ThermoGenesis Corp., a leading supplier of innovative products and services that process and store adult stem cells, said today it will seek stockholder approval of an authorization enabling its Board of Directors in its discretion to affect a reverse stock split in the range of one-for-three to one-for-five shares of common stock in the near future, if required to maintain NASDAQ listing. The authorization will be voted upon during a special meeting of stockholders to be held on Monday, August 9th.

19 Jun 2010

Childrens Hospital Los Angeles awarded $2.5M NIH grant to study risk of osteoporosis in spina bifida children

Tishya Wren, PhD, of The Saban Research Institute at Childrens Hospital Los Angeles, has received a $2.5 million grant from the National Institutes of Health - National Institute of Child Health and Human Development to study bone development in children with myelomeningocele, the most severe type of spina bifida .

19 Jun 2010

Recommended supplementation not sufficient to normalise vitamin D levels in RA patients: Study

Two separate studies have shown that vitamin D deficiency is common in patients with a range of rheumatic diseases, with over half of all patients having below the 'normal' healthy levels of vitamin D (48-145 nmol/L) in their bodies. A further study assessing response to vitamin D supplementation found that taking the recommended daily dose did not normalise vitamin D levels in rheumatic disease patients.

18 Jun 2010

NeoStem announces presentation on very small embryonic-like stem cells at ISSCR 2010

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that a poster authored by NeoStem-affiliated scientists will be presented in a presentation at the premier stem cell research event, the International Society for Stem Cell Research (ISSCR) 8th Annual Meeting in San Francisco on June 17, 2010.

18 Jun 2010

Antwerp ITM calls for change in WHO guidelines on Buruli ulcer

Buruli ulcers, one of the 'neglected tropical diseases' left aside by big pharma and governments alike, are reasonably well treatable, also in poor regions. But then more attention has to be paid to early diagnosis and correct treatment. This means the rules of the World Health Organization urgently need to be changed. So say scientists of the Antwerp Institute of Tropical Medicine (ITM), based on ten years of research in Congo.

18 Jun 2010

ASH selects 14 participants for 2010 MMSAP

The American Society of Hematology announces the selection of 14 participants for its 2010 Minority Medical Student Award Program, which encourages minority Medical students to purse an interest in hematology research. Award recipients will each receive the support of a research mentor and a career-development mentor, travel stipends to attend the ASH annual meeting, and a subscription to the scientific journal Blood, the official journal of ASH.

18 Jun 2010

Bone News and Research

Ingredients for an "anti-aging potion"

Spanish scientists propose human amniotic membrane as new tool for repairing damaged articular cartilage

Global weight management ingredients market to reach $13.9 million by 2015

Karolinska Institutet receives SEK 100M grant for Wallenberg Institute for Regenerative Medicine

Corgenix receives new European patent for AtherOx technology

Elevation of Smurf1 may play a role in molecular basis of PAH: Study

KYPHON ActivOs 10 Bone Cement with HA launched to treat patients with VCFs

Enobia reports positive interim data from ENB-0040 enzyme replacement therapy study for children with HPP

Pfizer announces voluntary withdrawal of Mylotarg from U.S. market following FDA request

Four-year clinical study results show sustained effect that Rheos System has on reducing hypertension

MDT aligned with AAP position statement on efforts to be made to save patient's natural dentition

Gamida Cell-Teva Joint Venture's StemEx program receives FDA Fast Track Designation

Ostarine increases muscle mass and strength in postmenopausal women: Study

Research findings open door to new model for health and fitness measurement

ThermoGenesis to seek stockholder approval for reverse stock split

Childrens Hospital Los Angeles awarded $2.5M NIH grant to study risk of osteoporosis in spina bifida children

Recommended supplementation not sufficient to normalise vitamin D levels in RA patients: Study

NeoStem announces presentation on very small embryonic-like stem cells at ISSCR 2010

Antwerp ITM calls for change in WHO guidelines on Buruli ulcer

ASH selects 14 participants for 2010 MMSAP

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News